ArticleAnnals of internal medicine2025

Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.

Jean-François Laprise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.